Structural requirements for targeting of surfactant protein B (SP-B) to secretory granules in vitro and in vivo.
about
Intracellular localization of processing events in human surfactant protein B biosynthesisEffect of acidic pH on the structure and lipid binding properties of porcine surfactant protein A. Potential role of acidification along its exocytic pathway.Passive sorting in maturing granules of AtT-20 cells: the entry and exit of salivary amylase and proline-rich proteinIdentification of a novel sequence involved in lysosomal sorting of the sphingolipid activator protein prosaposin.Pepsinogen C proteolytic processing of surfactant protein B.Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pHA Novel Approach for Ovine Primary Alveolar Epithelial Type II Cell Isolation and Culture from Fresh and Cryopreserved Tissue Obtained from Premature and Juvenile AnimalsConformational Stability of the NH2-Terminal Propeptide of the Precursor of Pulmonary Surfactant Protein SP-B.Developmental and genetic regulation of human surfactant protein B in vivo.Structure-function correlations of pulmonary surfactant protein SP-B and the saposin-like family of proteins.Mature Surfactant Protein-B Expression by Immunohistochemistry as a Marker for Surfactant System Development in the Fetal Sheep LungCharacterization of alveolar epithelial cells cultured in semipermeable hollow fibers.Post-translational processing of surfactant protein-C proprotein: targeting motifs in the NH(2)-terminal flanking domain are cleaved in late compartments.Structural requirements for intracellular targeting of SP-C proprotein.Synthetic processing of surfactant protein C by alevolar epithelial cells. The COOH terminus of proSP-C is required for post-translational targeting and proteolysis.Molecular structures and interactions of pulmonary surfactant components.An alternatively spliced surfactant protein B mRNA in normal human lung: disease implication.A stretch of 17 amino acids in the prosaposin C terminus is critical for its binding to sortilin and targeting to lysosomes.Maintenance of the mouse type II cell phenotype in vitro.Characterization of air-liquid interface culture of A549 alveolar epithelial cells.Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs.Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells.Secretion of surfactant protein C, an integral membrane protein, requires the N-terminal propeptide.
P2860
Q28139018-9E2AD8B9-1A31-49B8-89C3-16737BF93ED8Q30430673-9C841586-0198-48A6-B8CD-5D9540C32C05Q30442146-8ACFDCD1-14B9-4CEB-8F9B-CF3B517E5086Q30872172-B5D3FBBE-BBE0-493C-905F-43159F25E838Q33318635-2D1193A9-E916-4672-8937-799E72D21045Q33578198-0B3E26E8-B611-40AB-8ABE-0087B7B7C3EAQ35964724-ABE4AB42-1436-4B54-8132-46C9689B2691Q36068293-9DD07BDF-8C4F-48DC-AA63-68189C8B892DQ37396137-698D84FB-32DE-42FE-BBD7-688DB949F832Q38045186-985226E8-5C3B-4BAC-9906-2289F646752BQ39657623-82DE00CA-22E6-4785-8F03-E0800875B4CDQ39997388-02800467-E393-449D-9718-54A38B03426AQ40821326-01CDE625-A806-4CED-BE0D-00B8AA48F6B5Q40917719-6CC3D9C3-34C2-4DAE-A987-2B5908A879C0Q41034598-E9D6A5D9-8C5B-4ABE-9EB6-34DA4D1E2C79Q41434943-C2FCCF6D-A220-4BBF-B62B-960318B948FBQ41902269-44C83C61-63C2-4546-A910-B46D86006D1FQ41904597-0EE856B7-8365-4352-90C7-8B93DD537EC1Q44061703-C79EAE99-F1FE-4BF9-AAA5-5B9B97B19198Q47165409-A37E8C4D-0675-4D01-9D65-6C899D96D56AQ47627897-9A2C211B-7AE8-4F41-AC96-4409F4410026Q47719385-12354F1B-8CF5-4289-B78F-A185983F542CQ50336430-56635138-3A5E-4206-83BA-15A725102B9A
P2860
Structural requirements for targeting of surfactant protein B (SP-B) to secretory granules in vitro and in vivo.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Structural requirements for ta ...... granules in vitro and in vivo.
@en
type
label
Structural requirements for ta ...... granules in vitro and in vivo.
@en
prefLabel
Structural requirements for ta ...... granules in vitro and in vivo.
@en
P2093
P2860
P356
P1476
Structural requirements for ta ...... granules in vitro and in vivo.
@en
P2093
P2860
P304
19689-19695
P356
10.1074/JBC.271.33.19689
P407
P577
1996-08-01T00:00:00Z